Wizzard Software and MedivoxRx Technologies Announces TSSI as Newest Partner for Rex-The Talking Prescription Bottle.

PITTSBURGH -- Wizzard Software (OTCBB:WIZD) and its subsidiary, MedivoxRx Technologies, announced today that TSSI will begin offering prescriptions in Rex Talking Prescription Bottles. Since 1994, TSSI has provided durable medical equipment and respiratory medications throughout San Diego County. TSSI's success has been contingent upon supplying services in a humanistic manner to reach various cultures and bring positive changes to the lives of those using TSSI products.

"It is clearly evident that thousands of individuals encounter daily challenges managing their medications," said Lyn Schwartz, Director of Business Development for the TSSI Pharmacy Division. "Rex offers individuals the ability to maintain their dignity by living independently."

Rex-The Talking Bottle is an innovative assistive device that allows users to "hear" recorded medication instructions. Instructions or other important information are recorded into the base of the bottle and can be heard by simply pushing the button located on the side of the bottle. Completely portable, disposable and easy to use, Rex is perfect for the elderly, visually impaired and cognitively impaired, or anyone who can't read or understand their medication label instructions.

TSSI has been participating in community outreach by providing demonstrations of Rex-The Talking Prescription Bottle to a number of adult day care centers, residential programs and visually impaired facilities. The reaction of those in attendance has been very positive and appreciative, with one presentation at a center for the blind receiving a standing ovation.

"We are pleased to be able to work with TSSI and support their work in the community," said Gene Franz, General Manager, Solutions and Channels for MedivoxRx. "It is encouraging to see organizations such as TSSI being more than a business and using their resources to serve the community in which they do business."

Rex - The Talking Prescription Bottle provides a viable solution to the growing medication error problem in the United States. The Department of Health and Human Services reports that fewer than 30% of older adults take their medications properly. Further, pharmaceutical errors create $45-80 billion in additional medical spending with the number one error being identified as labeling problems and education. Also, the Journal of the American Medical Association reports medication errors and/or adverse drug events kill an estimated 100,000 persons annually and represent the fourth leading cause of death in the U.S.

About TSSI:

For more information, contact the TSSI Pharmacy Division at 619-337-3656.

About Wizzard Software:

Founded in 1996, Wizzard Software has become a leader in the speech technology application development market. Wizzard architects solutions to business problems using its expertise in consulting, speech development tools and building speech based applications for the Desktop and Internet. Wizzard has achieved global recognition because of its expertise with voice communication whether it is via computer or telephone. Wizzard's successes have lead to expanding speech technology opportunities in both the government and commercial sectors including several healthcare industry products and services. For more information, visit www.wizzardsoftware.com.

MedivoxRx is the originator of "Rex", the talking prescription pill bottle, which "talks" to the patient allowing them to distinguish what type of medication is in the bottle and hear critical information on dosage amounts and refill parameters. Additional information on MedivoxRx can be found at www.rxtalks.com.

Legal Notice

Legal Notice Regarding Forward-Looking Statements: "Forward-looking Statements" as defined in the Private Securities litigation Reform Act of 1995 may be included in this news release. These statements relate to future events or our future financial performance. These statements are only predictions and may differ materially from actual future results or events. We disclaim any intention or obligation to revise any forward-looking statements whether as a result of new information, future developments or otherwise. There are important risk factors that could cause actual results to differ from those contained in forward-looking statements, including, but not limited to risks associated with changes in general economic and business conditions, actions of our competitors, the extent to which we are able to develop new services and markets for our services, the time and expense involved in such development activities, the level of demand and market acceptance of our services, changes in our business strategies and acts of terror against the United States.